Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results.

OBJECTIVE We report our experience with the use of a left ventricular assist device (LVAD) as destination therapy (DT) for the management of patients with cardiac end-stage dystrophinopathies. METHODS From February 2011 to February 2016, 7 patients with dystrophinopathies and dilated cardiomyopathy (DCM) were treated with LVADs at our institution. Median… CONTINUE READING